Pregnancy in myasthenia gravis: a retrospective analysis of maternal and neonatal outcome from a large tertiary care centre in Germany
Purpose: Myasthenia gravis (MG) is a rare, potentially life-threatening autoimmune disease with fluctuating muscle weakness frequently affecting women of childbearing age. MG can affect maternal as well as neonatal outcome with risk of worsening of myasthenic symptoms in the mothers and risk of tran...
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
Springer
2024
|
| _version_ | 1811139637571223552 |
|---|---|
| author | Draxler, J Meisel, A Stascheit, F Stein, M Gerischer, L Mergenthaler, P Herdick, M Doksani, P Lehnerer, S Verlohren, S Hoffmann, S |
| author_facet | Draxler, J Meisel, A Stascheit, F Stein, M Gerischer, L Mergenthaler, P Herdick, M Doksani, P Lehnerer, S Verlohren, S Hoffmann, S |
| author_sort | Draxler, J |
| collection | OXFORD |
| description | Purpose: Myasthenia gravis (MG) is a rare, potentially life-threatening autoimmune disease with fluctuating muscle weakness frequently affecting women of childbearing age. MG can affect maternal as well as neonatal outcome with risk of worsening of myasthenic symptoms in the mothers and risk of transient neonatal myasthenia gravis (TNMG) and arthrogryposis multiplex congenita (AMC) or foetal acetylcholine receptor antibody-associated disorders (FARAD) in the neonates. Methods: Retrospective analysis of maternal and neonatal outcome in a cohort of pregnant MG patients treated at a tertiary care centre in Germany. Results: Overall, 66 pregnancies were analysed. During 40 (63%) pregnancies, women experienced a worsening of myasthenic symptoms, of whom 10 patients (15.7%) needed acute therapy with IVIg or plasma exchange. There was no case of myasthenic crisis. Rate of caesarean section was comparable to the overall C-section rate at our centre (38% vs. 40%). However, there was a slightly higher rate for operative vaginal delivery (15% vs. 10%) as potential indicator for fatiguing striated musculature in MG patients during the expulsion stage. Rate of TNMG as well as AMC was 3% (two cases each). Conclusions: Maternal and neonatal outcome in our cohort was favourable with a low rate of myasthenic exacerbations requiring acute therapies and a low rate of TNMG and AMC/FARAD. Our data might help neurologists and obstetricians to advice MG patients with desire to have children. |
| first_indexed | 2024-09-25T04:09:15Z |
| format | Journal article |
| id | oxford-uuid:a343a37b-5b0a-4246-8cfa-3dbd0680eddb |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-09-25T04:09:15Z |
| publishDate | 2024 |
| publisher | Springer |
| record_format | dspace |
| spelling | oxford-uuid:a343a37b-5b0a-4246-8cfa-3dbd0680eddb2024-06-12T20:07:58ZPregnancy in myasthenia gravis: a retrospective analysis of maternal and neonatal outcome from a large tertiary care centre in GermanyJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:a343a37b-5b0a-4246-8cfa-3dbd0680eddbEnglishJisc Publications RouterSpringer2024Draxler, JMeisel, AStascheit, FStein, MGerischer, LMergenthaler, PHerdick, MDoksani, PLehnerer, SVerlohren, SHoffmann, SPurpose: Myasthenia gravis (MG) is a rare, potentially life-threatening autoimmune disease with fluctuating muscle weakness frequently affecting women of childbearing age. MG can affect maternal as well as neonatal outcome with risk of worsening of myasthenic symptoms in the mothers and risk of transient neonatal myasthenia gravis (TNMG) and arthrogryposis multiplex congenita (AMC) or foetal acetylcholine receptor antibody-associated disorders (FARAD) in the neonates. Methods: Retrospective analysis of maternal and neonatal outcome in a cohort of pregnant MG patients treated at a tertiary care centre in Germany. Results: Overall, 66 pregnancies were analysed. During 40 (63%) pregnancies, women experienced a worsening of myasthenic symptoms, of whom 10 patients (15.7%) needed acute therapy with IVIg or plasma exchange. There was no case of myasthenic crisis. Rate of caesarean section was comparable to the overall C-section rate at our centre (38% vs. 40%). However, there was a slightly higher rate for operative vaginal delivery (15% vs. 10%) as potential indicator for fatiguing striated musculature in MG patients during the expulsion stage. Rate of TNMG as well as AMC was 3% (two cases each). Conclusions: Maternal and neonatal outcome in our cohort was favourable with a low rate of myasthenic exacerbations requiring acute therapies and a low rate of TNMG and AMC/FARAD. Our data might help neurologists and obstetricians to advice MG patients with desire to have children. |
| spellingShingle | Draxler, J Meisel, A Stascheit, F Stein, M Gerischer, L Mergenthaler, P Herdick, M Doksani, P Lehnerer, S Verlohren, S Hoffmann, S Pregnancy in myasthenia gravis: a retrospective analysis of maternal and neonatal outcome from a large tertiary care centre in Germany |
| title | Pregnancy in myasthenia gravis: a retrospective analysis of maternal and neonatal outcome from a large tertiary care centre in Germany |
| title_full | Pregnancy in myasthenia gravis: a retrospective analysis of maternal and neonatal outcome from a large tertiary care centre in Germany |
| title_fullStr | Pregnancy in myasthenia gravis: a retrospective analysis of maternal and neonatal outcome from a large tertiary care centre in Germany |
| title_full_unstemmed | Pregnancy in myasthenia gravis: a retrospective analysis of maternal and neonatal outcome from a large tertiary care centre in Germany |
| title_short | Pregnancy in myasthenia gravis: a retrospective analysis of maternal and neonatal outcome from a large tertiary care centre in Germany |
| title_sort | pregnancy in myasthenia gravis a retrospective analysis of maternal and neonatal outcome from a large tertiary care centre in germany |
| work_keys_str_mv | AT draxlerj pregnancyinmyastheniagravisaretrospectiveanalysisofmaternalandneonataloutcomefromalargetertiarycarecentreingermany AT meisela pregnancyinmyastheniagravisaretrospectiveanalysisofmaternalandneonataloutcomefromalargetertiarycarecentreingermany AT stascheitf pregnancyinmyastheniagravisaretrospectiveanalysisofmaternalandneonataloutcomefromalargetertiarycarecentreingermany AT steinm pregnancyinmyastheniagravisaretrospectiveanalysisofmaternalandneonataloutcomefromalargetertiarycarecentreingermany AT gerischerl pregnancyinmyastheniagravisaretrospectiveanalysisofmaternalandneonataloutcomefromalargetertiarycarecentreingermany AT mergenthalerp pregnancyinmyastheniagravisaretrospectiveanalysisofmaternalandneonataloutcomefromalargetertiarycarecentreingermany AT herdickm pregnancyinmyastheniagravisaretrospectiveanalysisofmaternalandneonataloutcomefromalargetertiarycarecentreingermany AT doksanip pregnancyinmyastheniagravisaretrospectiveanalysisofmaternalandneonataloutcomefromalargetertiarycarecentreingermany AT lehnerers pregnancyinmyastheniagravisaretrospectiveanalysisofmaternalandneonataloutcomefromalargetertiarycarecentreingermany AT verlohrens pregnancyinmyastheniagravisaretrospectiveanalysisofmaternalandneonataloutcomefromalargetertiarycarecentreingermany AT hoffmanns pregnancyinmyastheniagravisaretrospectiveanalysisofmaternalandneonataloutcomefromalargetertiarycarecentreingermany |